<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Okubo Y</submitter><funding>Japan Society for the Promotion of Science</funding><pagination>e70052</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12508520</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(6)</volume><pubmed_abstract>Cribriform pattern and intraductal carcinoma of the prostate are recognized adverse histological features, yet their prognostic value in treatment-naïve metastatic disease remains uncertain. We conducted a single-center retrospective study of 183 biopsy-proven prostate carcinomas (105 with metastatic castration-sensitive prostate carcinoma and 78 non-metastatic high-grade cases) diagnosed between 2017 and 2024. Cribriform pattern, intraductal carcinoma of the prostate, and coagulative tumor necrosis were recorded per core and summarized as patient-level binary status and as semiquantitative proportions per cancer-positive core. Two multivariable logistic regression models (binary and semiquantitative) were fitted, and receiver operating characteristic (ROC) analysis evaluated the discrimin</pubmed_abstract><journal>The journal of pathology. Clinical research</journal><pubmed_title>Cribriform pattern and IDC-P in prostate biopsies: prognostic relevance and reporting in metastatic disease.</pubmed_title><pmcid>PMC12508520</pmcid><funding_grant_id>25K10294</funding_grant_id><pubmed_authors>Aigase T</pubmed_authors><pubmed_authors>Washimi K</pubmed_authors><pubmed_authors>Kishida T</pubmed_authors><pubmed_authors>Yokose T</pubmed_authors><pubmed_authors>Yuguchi S</pubmed_authors><pubmed_authors>Hiroshima Y</pubmed_authors><pubmed_authors>Suzuki A</pubmed_authors><pubmed_authors>Yoshioka E</pubmed_authors><pubmed_authors>Sato S</pubmed_authors><pubmed_authors>Matsuyama R</pubmed_authors><pubmed_authors>Miyagi Y</pubmed_authors><pubmed_authors>Hasegawa C</pubmed_authors><pubmed_authors>Yamamoto Y</pubmed_authors><pubmed_authors>Kasajima R</pubmed_authors><pubmed_authors>Nakaigawa N</pubmed_authors><pubmed_authors>Narimatsu H</pubmed_authors><pubmed_authors>Okubo Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cribriform pattern and IDC-P in prostate biopsies: prognostic relevance and reporting in metastatic disease.</name><description>Cribriform pattern and intraductal carcinoma of the prostate are recognized adverse histological features, yet their prognostic value in treatment-naïve metastatic disease remains uncertain. We conducted a single-center retrospective study of 183 biopsy-proven prostate carcinomas (105 with metastatic castration-sensitive prostate carcinoma and 78 non-metastatic high-grade cases) diagnosed between 2017 and 2024. Cribriform pattern, intraductal carcinoma of the prostate, and coagulative tumor necrosis were recorded per core and summarized as patient-level binary status and as semiquantitative proportions per cancer-positive core. Two multivariable logistic regression models (binary and semiquantitative) were fitted, and receiver operating characteristic (ROC) analysis evaluated the discrimin</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-04T08:42:43.882Z</modification><creation>2026-05-07T03:09:14.306Z</creation></dates><accession>S-EPMC12508520</accession><cross_references><pubmed>41063546</pubmed><doi>10.1002/2056-4538.70052</doi></cross_references></HashMap>